24
Participants
Start Date
January 31, 2016
Primary Completion Date
March 20, 2023
Study Completion Date
March 20, 2023
ITF (Inulin/OFS 75/25)
Participants will consume 16 g/day ITF
Placebo
Participants will consume 16 g/day maltodextrin
Kaplan Medical Center, Rehovot
Lead Sponsor
Kaplan Medical Center
OTHER